DermTech, Inc.

DermTech, Inc., the precision dermatology company that reached public markets through its business combination with Constellation Alpha Capital Corp (CNAC), filed an 8-K with the Securities and Exchange Commission on June 5, 2023. Constellation Alpha Capital Corp was a healthcare-focused special purpose acquisition company that completed its IPO in 2017, targeting opportunities in the life sciences and medical technology sector. The SPAC merger closed in 2019, bringing DermTech's non-invasive genomic diagnostics platform — primarily focused on skin cancer detection — onto public markets. The June 2023 filing represents continued post-merger disclosure activity for the combined entity. Sign up for full data access at SpacDesk to explore complete filing histories, deal timelines, and SPAC analytics across hundreds of transactions.